Inflammatory/hemostatic biomarkers and cardiovascular risk: Coming of age?

Journal of Thrombosis and Haemostasis

Volumn 5, Issue 6, 2007, Pages 1125-1127

  Lowe, Gordon D O ^a  

^a UNIVERSITY OF GLASGOW   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

BIOLOGICAL MARKER; BLOOD CLOTTING FACTOR 8C; C REACTIVE PROTEIN; CYTOKINE; FIBRINOGEN; INTERLEUKIN 6;

AGE; ARTERY DISEASE; CARDIOVASCULAR DISEASE; CARDIOVASCULAR RISK; CEREBROVASCULAR ACCIDENT; DISEASE ASSOCIATION; FIBRINOGEN BLOOD LEVEL; HEMOSTASIS; HUMAN; HYPERCOAGULABILITY; HYPERTENSION; INFLAMMATION; NOTE; PREDICTION; PRIORITY JOURNAL; RISK ASSESSMENT; RISK FACTOR; SMOKING;

AGED; AGING; BIOLOGICAL MARKERS; CARDIOVASCULAR DISEASES; FEMALE; HEMOSTASIS; HUMANS; INFLAMMATION MEDIATORS; MALE; RISK FACTORS;

EID: 34250210808     PISSN: 15387933     EISSN: 15387836     Source Type: Journal    
DOI: 10.1111/j.1538-7836.2007.02529.x     Document Type: Note

References (20)

1. Zakai NA, Katz R, Jenny NS, Psaty BM, Reiner AP, Schwartz SM, Cushman M. Inflammation biomarkers and cardiovascular risk in the elderly: The Cardiovascular Health Study. J Thromb Haemost 2007; 5: 1128-35.
2. Rothwell PM, Coull AJ, Silver LE, Fairhead JF, Giles MF, Lovelock CE, Redgrave JNE, Bull LM, Welch SJV, Cutherbertson FC, Binney LE, Gutnikov SA, Anslow P, Banning AP, Mantz D, Mehta Z, for the Oxford Vascular Study (2005). Population-based study of event-rate, incidence, case fatality, and mortality for all acute vascular events in all arterial territories (Oxford Vascular Study). Lancet 366; 1773-83.
3. Lowe GDO. Circulating inflammatory markers and risks of cardiovascular and non-cardiovascular disease. J Thromb Haemost 2005; 3: 1618-27.
4. McDonald L, Edgill M. Coagulability of the blood in ischaemic heart disease. Lancet 1957; ii: 457-60.
5. Lowe GDO, Woodward M, Rumley A, Morrison CE, Nieuwenhuizen W. Associations of plasma fibrinogen assays, C-reactive protein and interleukin-6 with previous myocardial infarction. J Thromb Haemost 2003; 1: 2312-6.
6. Kerr R, Stirling D, Ludlam CA. Interleukin-6 and haemostasis. Brit J Haematol 2001; 115: 3-12.
7. Hansson GK. Inflammation, atherosclerosis, and coronary artery disease. N Engl J Med 2005; 352: 1685-95.
8. Wannamethee SG, Tchernova J, Whincup P, Lowe GDO, Kelly A, Rumley A, Wallace AM, Sattar N. Plasma leptin: Associations with metabolic, inflammatory and haemostatic risk factors for cardiovascular disease. Atherosclerosis 2007; 191: 418-26.
9. Fibrinogen Studies Collaboration. Collaborative meta-analysis of prospective observational studies of plasma fibrinogen and cardiovascular disease. Eur J Cardiovasc Prev Rehabil 2004; 11: 9-17.
10. Fibrinogen Studies Collaboration. Plasma fibrinogen level and the risk of major cardiovascular diseases and non-vascular mortality: An individual participant meta-analysis. JAMA 2005; 294: 1799-809.
11. Rumley A, Emberson JR, Wannamethee SG, Lennon L, Whincup PH, Lowe GDO. Effects of older age on fibrin D-dimer, C-reactive protein and other haemostatic and inflammatory variables in men aged 60-79years. J Thromb Haemost 2006; 4: 982-7.
12. Smith A, Patterson C, Yarnell J, Rumley A, Ben-Shlomo Y, Lowe G. Which hemostatic markers add to the predictive value of conventional risk factors for coronary heart disease and ischemic stroke? The Caerphilly Study. Circulation 2005; 112: 3080-7.
13. Tzoulaki I, Murray GD, Lee AJ, Rumley A, Lowe GDO, Fowkes FGR. Relative value of inflammatory, hemostatic and rheological variables for incident myocardial infarction and stroke: The Edinburgh Artery Study. Circulation 2007; in press.
14. Tzoulaki I, Murray GD, Lee AJ, Rumley A, Lowe GDO, Fowkes FGR. Inflammatory, haemostatic, and rheological markers for incident peripheral arterial disease: Edinburgh Artery Study. Eur Heart J 2007; 28: 354-62.
15. Lowe GDO. Can haematological tests predict cardiovascular risk? The 2005 Kettle Lecture. Br J Haematol 2006; 133: 232-50.
16. Emberson J, Whincup P, Morris R, Walker M, Lowe G, Rumley A. Extent of regression dilution for established and novel coronary risk factors: results from the British Regional Heart Study. Eur J Cardiovasc Prev Rehabil 2004; 11: 125-34.
17. Lawlor DA, Davey Smith G, Rumley A, Lowe GDO, Ebrahim S. Associations of fibrinogen and C-reactive protein with prevalent and incident coronary heart disease are attenuated by adjustment for confounding factors: British Women's Heart and Health Study. Thromb Haemost 2005; 93: 955-63.
18. O'Reilly DS, Upton MN, Caslake MJ, Robertson M, Norrie J, McConnachie A, Watt GCM, Packard CJ. Midspan and WOSCOPS study groups: Plasma C reactive protein concentration indicates a direct relation between systemic inflammation and social deprivation. Heart 2006; 92: 533-5.
19. Tunstall-Pedoe H, Woodward M, for the SIGN group on risk estimation. By neglecting deprivation, cardiovascular risk scoring will exacerbate social gradients in disease. Heart 2006; 92: 307-10.
20. Woodward M, Brindle P, Tunstall-Pedoe H, for the SIGN group on risk estimation. Adding social deprivation and family history to cardiovascular risk assessment: The ASSIGN score from the Scottish Heart Health Extended Cohort (SHHEC). Heart 2007; 93: 172-6.